• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Mult Scler Relat Disord . Can coronavirus disease 2019 (COVID-19) trigger exacerbation of multiple sclerosis? A retrospective study

tetano

Editor, Senior Moderator
Mult Scler Relat Disord


. 2021 Apr 11;52:102947.
doi: 10.1016/j.msard.2021.102947. Online ahead of print.
Can coronavirus disease 2019 (COVID-19) trigger exacerbation of multiple sclerosis? A retrospective study


Mahdi Barzegar[SUP] 1 [/SUP], Saeed Vaheb[SUP] 2 [/SUP], Omid Mirmosayyeb[SUP] 1 [/SUP], Alireza Afshari-Safavi[SUP] 3 [/SUP], Nasim Nehzat[SUP] 4 [/SUP], Vahid Shaygannejad[SUP] 5 [/SUP]



Affiliations
Free PMC article

Abstract

The effect of coronavirus disease (COVID-19) on the risk of relapse in multiple sclerosis (MS) have been unknown. In this retrospective study of 41 relapsing-remitting MS patients, number of relapses in pre-defined at risk-period (ARP) was compared with the previous two years. During the previous two years, a total of 32 attacks was reported, which 5 (15.6%) were during the at-risk period. After adjusting for age and sex, there was an increased risk of attack during ARP compared to the previous two years (RR: 2.566, 95%CI: 1.075-6.124, P=0.034). Our preliminary study suggested that COVID-19 can trigger exacerbation of MS.

Keywords: Coronavirus; Exacerbation; Infection; Multiple sclerosis; Relapse.
 
Back
Top Bottom